Cove Private Wealth
BMY icon

Cove Private Wealth’s Bristol-Myers Squibb BMY Stock Holding History

Cove Private Wealth’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$729K Buy
11,684
+109
+0.9% +$6.89K 0.13% 115
2026
Q2 		$667K Hold
11,575
– – 0.13% 121
2026
Q1 		$702K Hold
11,575
– – 0.16% 104
2025
Q4 		$624K Sell
11,575
-695
-6% -$33.4K 0.19% 97
2025
Q3 		$553K Sell
12,270
-1,095
-8% -$51.1K 0.18% 99
2025
Q2 		$619K Buy
13,365
+2,020
+18% +$99.2K 0.22% 91
2025
Q1 		$692K Buy
11,345
+2,350
+26% +$137K 0.36% 69
2024
Q4 		$509K Hold
8,995
– – 0.31% 68
2024
Q3 		$465K Sell
8,995
-1,175
-12% -$55.1K 0.36% 59
2024
Q2 		$422K Hold
10,170
– – 0.34% 61
2024
Q1 		$552K Hold
10,170
– – 0.47% 53
2023
Q4 		$522K Buy
+10,170
New +$534K 0.49% 53

Other funds holding BMY

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Pzena Investment Management
Pzena Investment Management New York $34.1B AUM 26.62% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $85.7B AUM 51.02% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $127B AUM 33.25% 1-Year Est. Return
Amundi
Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $54.1B AUM 39.29% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return

Cove Private Wealth's BMY Position: Q3 2026 in Review

Cove Private Wealth increased its Bristol-Myers Squibb (BMY) stake by 0.94% in Q3 2026, buying an estimated $6.89K and bringing the position to 11,684 shares worth $729K. The position accounts for 0.13% of the portfolio, ranked #115.

Cove Private Wealth first reported a position in BMY in Q4 2023 and has held it in 12 quarters since. 1,630 funds tracked by Wall St. Rank hold BMY as of Q3 2026.

  • Cove Private Wealth held 11,684 shares of Bristol-Myers Squibb worth $729K as of Q3 2026.
  • Cove Private Wealth bought 109 Bristol-Myers Squibb shares in Q3 2026, an estimated $6.89K.
  • Bristol-Myers Squibb made up 0.13% of Cove Private Wealth's portfolio in Q3 2026, its #115 holding.
  • Cove Private Wealth first reported a position in Bristol-Myers Squibb in Q4 2023 and has held it in 12 quarters since.
  • 1,630 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2026.

Based on Cove Private Wealth's 13F filing for Q3 2026, filed 28 Oct 2026.